EUVIMEDEUVIMED entdecken
Crossref

Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration

Iga Walczak, Alicja Braczko, Aleksandra Paterek, Filip Rolski, Krzysztof Urbanowicz, Maria Tarnawska, Roksana Knapczyk, Aleksandra Parzuchowska, Ryszard T Smoleński, Marcin Hellmann, Michał Mączewski, Barbara Kutryb-Zając

Cellular Physiology and Biochemistry · 2025

DOI: 10.33594/000000772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, 2025. Verfasst von Iga Walczak und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical University of Gdansk, Gdańsk, Poland. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Sodium-Glucose Transporter 2 Inhibitors, Energy Metabolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Gefördert von: The National Science Centre of Poland (NCN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsGlucosidesSodium-Glucose Transporter 2 InhibitorsEnergy MetabolismEndothelial CellsMitochondriaAnimalsMiceMice, Inbred C57BLNitric OxideHumansMaleHeart FailureSodium-Glucose Transporter 2Cell LineCell Respiration

Stichwörter der Autor:innen

Dapagliflozin; Cardiac endothelial cells; Nitric oxide; Energy metabolism

Substanzen

Benzhydryl CompoundsdapagliflozinGlucosidesSodium-Glucose Transporter 2 InhibitorsNitric OxideSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Department of Biochemistry, Medical University of Gdansk, Gdańsk, Poland.
  • Department of Clinical Physiology, The Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Department of Cardiac Diagnostics, Medical University of Gdansk, Gdańsk, Poland.
  • Department of Biochemistry, Medical University of Gdansk, Gdańsk, Poland, b.kutryb-zajac@gumed.edu.pl.
  • Centre of Experimental Cardiooncology, Medical University of Gdansk, Gdańsk, Poland.

Förderung

  • The National Science Centre of Poland (NCN)

Zitieren

APA

Walczak, I., Braczko, A., Paterek, A., Rolski, F., Urbanowicz, K., Tarnawska, M., Knapczyk, R., Parzuchowska, A., Smoleński, R. T., Hellmann, M., Mączewski, M., & Kutryb-Zając, B. (2025). Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000772

Vancouver

Walczak I, Braczko A, Paterek A, Rolski F, Urbanowicz K, Tarnawska M, et al. Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000772

BibTeX
@article{Walczak2025,
  author = {Walczak, Iga and Braczko, Alicja and Paterek, Aleksandra and Rolski, Filip and Urbanowicz, Krzysztof and Tarnawska, Maria and Knapczyk, Roksana and Parzuchowska, Aleksandra and Smoleński, Ryszard T and Hellmann, Marcin and Mączewski, Michał and Kutryb-Zając, Barbara},
  title = {Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration},
  journal = {Cellular Physiology and Biochemistry},
  year = {2025},
  doi = {10.33594/000000772}
}
Kostenlos starten →